Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Nirsevimab Monoclonal Antibody Memo (2024-2025)
This memo outlines recommendations and an implementation plan for nirsevimab (Beyfortus™), a long-acting monoclonal antibody effective against respiratory syncytial virus (RSV), at Lucile Packard Children’s …
Ask aRCie
Impact of Nirsevimab on Admission to a Spanish Pediatric Intensive Care Unit Because of RSV Bronchiolitis: Unicentric Observational Study from 2017 to 2024
This letter describes admissions to a pediatric critical care unit (PICU) because of acute bronchiolitis caused by respiratory syncytial virus. The study looked at a …
Nirsevimab (Beyfortus) Guide to Prevent Severe RSV in Infants and Toddlers
This one-page infographic provides guidance on using nirsevimab (Beyfortus) to prevent severe RSV in infants and toddlers. It addresses high-risk conditions in children, as well …
Beyfortus® For Prevention of Respiratory Syncytial Virus (RSV) in Infants
This webpage provides a pharmacy update on the use of Beyfortus for the prevention of RSV in infants. The FDA approved nirsevimab for infants and …
Guidelines for Inpatient Administration of Nirsevimab to Infants and Children
2024
· University of Michigan
This 4-page document explain how to give nirsevimab to infants and children in hospitals. It describes dosing based on age and weight, especially after heart …
Pharmacy Podcast Episode 162: Nirsevimab: Prevent RSV or Let it Be?
2024
· Mayo Clinic
This podcast discusses nirsevimab and its role in preventing respiratory syncytial virus (RSV) in infants. Kimberly James, PharmD discusses which patients could benefit from nirsevimab, …
Vaccine Resources: Nirsevimab Effectiveness, AI in Health Communication and Updated VISs
This post is about vaccine resources, focusing on the effectiveness of nirsevimab, a medication used to prevent respiratory infections in infants. It describes how artificial …
News & Views: Nirsevimab Means Brushing Up on Passive Immunity Talking Points
This post is about nirsevimab, a new treatment that helps protect babies from respiratory illnesses. It describes how nirsevimab provides passive immunity, which means it …
RSV Prevention Within Reach for Older Infants and Toddlers: The Role of Active Immunization
This article reviews efforts to prevent RSV in older infants and toddlers through active immunization. It highlights the global impact of RSV, especially in young …
The Assessment of Future RSV Immunizations: How to Protect All Infants?
2022
· University Medical Centre Utrecht,
· Paris Cité University,
· University of Lübeck,
· University of Parma,
· Comunidad de Madrid,
· Università Degli Studi Di Milano Statale,
· European Foundation for the Care of Newborn Infants (EFCNI),
· Nihon University School of Medicine,
· Beijing Children's Hospital,
· University of Thessaly,
· University of Southampton,
· University Hospital Southampton NHS Foundation Trust,
· Bambino Gesù Children Hospital
This article explores ways to protect infants from RSV, a common virus that can cause serious illness. It describes different immunization strategies being developed to …